Table 3.
Treatment Strategy | Persons Treated, % |
PCR-Positive Infections Treated, % |
Mosquito Infections Avoided, %a |
---|---|---|---|
All RDT-positive individuals | 0.2 | 8.9 | 28.2–44.7 |
All members of households with ≥1 RDT-positive individual | 1.0 | 13.0 | 31.4–52.2 |
All living within given radius of RDT-positive individual | |||
<100 m | 4.4 | 16.2 | 34.0–53.9 |
<300 m | 13.9 | 30.1 | 44.9–61.5 |
<1000 m | 57.6 | 65.9 | 73.1–81.2 |
All individual with positive results | |||
AMA | 19.6 | 45.7 | 47.9–50.3 |
MSP-119 | 14.7 | 41.1 | 41.8–42.6 |
AMA or MSP-119 | 26.4 | 56.8 | 62.0–66.9 |
All members of households with | |||
≥1 AMA-positive individual | 49.9 | 67.0 | 71.9–77.2 |
≥1 MSP-119–positive indivudal | 41.6 | 61.0 | 64.7–68.8 |
≥1 AMA- or MSP-119–positive individual | 62.8 | 76.8 | 82.6–88.1 |
Abbreviations: PCR, polymerase chain reaction; RDT, rapid diagnostic test.
aShown as range, with lower estimates assuming infectivity rates in reference [7] and higher estimates according to reference [31].